Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.

Balfe P, Shapiro S, Hsu M, Buckner C, Harouse JM, Cheng-Mayer C.

Virology. 2004 Jan 5;318(1):267-79.

2.

Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus.

Reyes RA, Canfield DR, Esser U, Adamson LA, Brown CR, Cheng-Mayer C, Gardner MB, Harouse JM, Luciw PA.

J Virol. 2004 Feb;78(4):2121-30.

3.

CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Harouse JM, Buckner C, Gettie A, Fuller R, Bohm R, Blanchard J, Cheng-Mayer C.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10977-82. Epub 2003 Sep 8.

5.

Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants.

Buckner CM, Gettie A, Tan RC, Eshetu T, Ratterree M, Blanchard J, Cheng-Mayer C, Harouse JM.

J Med Primatol. 2002 Aug;31(4-5):164-70.

PMID:
12390538
6.

Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIV(SF33A2) map to env region.

Harouse JM, Gettie A, Tan RC, Eshetu T, Ratterree M, Blanchard J, Cheng-Mayer C.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):222-8.

PMID:
11464140
7.

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).

Harouse JM, Gettie A, Eshetu T, Tan RC, Bohm R, Blanchard J, Baskin G, Cheng-Mayer C.

J Virol. 2001 Feb;75(4):1990-5.

9.

In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein.

Tan RC, Harouse JM, Gettie A, Cheng-Mayer C.

J Med Primatol. 1999 Aug-Oct;28(4-5):164-8.

PMID:
10593481
10.

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C.

Science. 1999 Apr 30;284(5415):816-9.

11.

In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome.

Harouse JM, Tan RC, Gettie A, Dailey P, Marx PA, Luciw PA, Cheng-Mayer C.

J Med Primatol. 1998 Apr-Jun;27(2-3):81-6.

PMID:
9747947
12.

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.

Harouse JM, Tan RC, Gettie A, Dailey P, Marx PA, Luciw PA, Cheng-Mayer C.

Virology. 1998 Aug 15;248(1):95-107.

14.

HIV-1 infection of cultured human adult oligodendrocytes.

Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, González-Scarano F.

Virology. 1996 Mar 1;217(1):211-9.

16.

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F.

Science. 1991 Jul 19;253(5017):320-3.

PMID:
1857969
17.

Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway.

Harouse JM, Laughlin MA, Pletcher C, Friedman HM, Gonzalez-Scarano F.

J Leukoc Biol. 1991 Jun;49(6):605-9.

PMID:
2026965
18.

Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1.

Ho WZ, Harouse JM, Rando RF, Gönczöl E, Srinivasan A, Plotkin SA.

J Gen Virol. 1990 Jan;71 ( Pt 1):97-103.

PMID:
2154540
19.

CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F.

J Virol. 1989 Jun;63(6):2527-33.

20.

Human choroid plexus cells can be latently infected with human immunodeficiency virus.

Harouse JM, Wroblewska Z, Laughlin MA, Hickey WF, Schonwetter BS, Gonzalez-Scarano F.

Ann Neurol. 1989 Apr;25(4):406-11.

PMID:
2653176

Supplemental Content

Loading ...
Support Center